BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 24664954)

  • 21. Characterization of major histocompatibility complex class I and class II genes from the Tasmanian devil (Sarcophilus harrisii).
    Siddle HV; Sanderson C; Belov K
    Immunogenetics; 2007 Sep; 59(9):753-60. PubMed ID: 17673996
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification and analysis of divergent immune gene families within the Tasmanian devil genome.
    Morris KM; Cheng Y; Warren W; Papenfuss AT; Belov K
    BMC Genomics; 2015 Nov; 16():1017. PubMed ID: 26611146
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analyses of leucocytes in blood and lymphoid tissues from mink infected with Aleutian mink disease parvovirus (AMDV).
    Chen W; Aasted B
    Vet Immunol Immunopathol; 1998 Jun; 63(4):317-34. PubMed ID: 9656422
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The toll-like receptor ligands Hiltonol
    Patchett AL; Tovar C; Corcoran LM; Lyons AB; Woods GM
    Dev Comp Immunol; 2017 Nov; 76():352-360. PubMed ID: 28689773
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An Examination of the Development and Localization of Key Immune Cells in Developing Pouch Young of the Red-Tailed Phascogale (Phascogale calura).
    Borthwick CR; Young LJ; Old JM
    Anat Rec (Hoboken); 2019 Nov; 302(11):1985-2002. PubMed ID: 31120185
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pathogenesis and molecular biology of a transmissible tumor in the Tasmanian devil.
    Bender HS; Marshall Graves JA; Deakin JE
    Annu Rev Anim Biosci; 2014 Feb; 2():165-87. PubMed ID: 25384139
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The development of the immune tissues in marsupial pouch young.
    Borthwick CR; Young LJ; Old JM
    J Morphol; 2014 Jul; 275(7):822-39. PubMed ID: 24469962
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mature dendritic cells make clusters with T cells in the invasive margin of colorectal carcinoma.
    Suzuki A; Masuda A; Nagata H; Kameoka S; Kikawada Y; Yamakawa M; Kasajima T
    J Pathol; 2002 Jan; 196(1):37-43. PubMed ID: 11748640
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lessons learnt from the Tasmanian devil facial tumour regarding immune function in cancer.
    Peel E; Belov K
    Mamm Genome; 2018 Dec; 29(11-12):731-738. PubMed ID: 30225648
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genomic restructuring in the Tasmanian devil facial tumour: chromosome painting and gene mapping provide clues to evolution of a transmissible tumour.
    Deakin JE; Bender HS; Pearse AM; Rens W; O'Brien PC; Ferguson-Smith MA; Cheng Y; Morris K; Taylor R; Stuart A; Belov K; Amemiya CT; Murchison EP; Papenfuss AT; Graves JA
    PLoS Genet; 2012; 8(2):e1002483. PubMed ID: 22359511
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterisation of non-classical MHC class I genes in the Tasmanian devil (Sarcophilus harrisii).
    Cheng Y; Belov K
    Immunogenetics; 2014 Dec; 66(12):727-35. PubMed ID: 25267059
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lymphoid organ development in rabbits: major lymphocyte subsets.
    Jeklova E; Leva L; Faldyna M
    Dev Comp Immunol; 2007; 31(6):632-44. PubMed ID: 17126399
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Histopathological and immunohistochemical analysis of lymphoid follicles in labial salivary glands in primary and secondary Sjögren's syndrome.
    Prochorec-Sobieszek M; Wagner T; Loukas M; Chwalińska-Sadowska H; Olesińska M
    Med Sci Monit; 2004 Apr; 10(4):BR115-21. PubMed ID: 15039641
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of antibody V segment diversity in the Tasmanian devil (Sarcophilus harrisii).
    Ujvari B; Belov K
    Vet Immunol Immunopathol; 2015 Oct; 167(3-4):156-65. PubMed ID: 26300316
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antigen-presenting genes and genomic copy number variations in the Tasmanian devil MHC.
    Cheng Y; Stuart A; Morris K; Taylor R; Siddle H; Deakin J; Jones M; Amemiya CT; Belov K
    BMC Genomics; 2012 Mar; 13():87. PubMed ID: 22404855
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development of early apopotosis and changes in lymphocyte subsets in lymphoid organs of mice orally inoculated with nivalenol.
    Poapolathep A; Nagata T; Suzuki H; Kumagai S; Doi K
    Exp Mol Pathol; 2003 Aug; 75(1):74-9. PubMed ID: 12834628
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mouse Model of Devil Facial Tumour Disease Establishes That an Effective Immune Response Can be Generated Against the Cancer Cells.
    Pinfold TL; Brown GK; Bettiol SS; Woods GM
    Front Immunol; 2014; 5():251. PubMed ID: 24904594
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The appearance and distribution of mature T and B cells in the developing immune tissues of the stripe-faced dunnart (Sminthopsis macroura).
    Old JM; Selwood L; Deane EM
    J Anat; 2004 Jul; 205(1):25-33. PubMed ID: 15255959
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Induced Pluripotent Stem Cell-Derived Mesenchymal Stem Cells from the Tasmanian Devil (
    Weeratunga P; Shahsavari A; Fennis E; Wolvetang EJ; Ovchinnikov DA; Whitworth DJ
    Stem Cells Dev; 2020 Jan; 29(1):25-37. PubMed ID: 31709909
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Class II transactivator induces expression of MHC-I and MHC-II in transmissible Tasmanian devil facial tumours.
    Ong CEB; Cheng Y; Siddle HV; Lyons AB; Woods GM; Flies AS
    Open Biol; 2022 Oct; 12(10):220208. PubMed ID: 36259237
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.